Benzodiazepine receptor protein identified and visualized in brain tissue by a photoaffinity label.

AUTOR(ES)

Möhler, H

RESUMO

Flunitrazepam, a potent benzodiazepine, reversibly binds to the benzodiazepine receptor with high affinity. When irradiated with UV light, flunitrazepam was irreversibly linked to brain tissue. Incorporation of [3H]flunitrazepam was inhibited by other benzodiazepines with a potency corresponding to their affinity for the benzodiazepine receptor. Photolabeling with flunitrazepam reduced the number of benzodiazepine receptors determined by reversible binding of benzodiazepines, whereas the apparent affinity of the remaining receptors was unchanged. Half-maximal incorporation of flunitrazepam occurred at a concentration similar to the apparent dissociation constant of flunitrazepam. Thus, flunitrazepam appears to be a photoaffinity label for the benzodiazepine receptor. The receptor component photolabeled with flunitrazepam was a protein of molecular weight 50,000. Its location in cerebral and cerebellar cortex slices could be visualized by electron microscopic autoradiography. A predominant localization of benzodiazepine receptors in regions of synaptic constants, including those formed by GABAergic neurons (GABA is gamma-aminobutyric acid), was observed.

Documentos Relacionados

• Probing the peptide binding site of the cAMP-dependent protein kinase by using a peptide-based photoaffinity label.
• Identification of Intracellular Carbonic Anhydrase in Chlamydomonas reinhardtii with a Carbonic Anhydrase-Directed Photoaffinity Label.
• Herpes simplex virus envelopment and maturation studied by fracture label.
• (125I)iodoazidococaine, a photoaffinity label for the haloperidol-sensitive sigma receptor.
• Both alpha and beta subunits of human choriogonadotropin photoaffinity label the hormone receptor.